Evaluating MRI technology for guided procedures
Evaluation of Non Significant Risk Operation Magnetic Resonance Imaging for MR Guided Ablation Using the Philips MRI
NA · Mayo Clinic · NCT04880226
This study is testing new MRI technology to see if it can make MRI-guided procedures like biopsies and ablations faster and provide clearer images for better patient care.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Mayo Clinic (other) |
| Locations | 1 site (Rochester, Minnesota) |
| Trial ID | NCT04880226 on ClinicalTrials.gov |
What this trial studies
This study evaluates advanced magnetic resonance imaging (MRI) methods in the intraoperative MRI (iMRI) environment to enhance patient care. It focuses on assessing whether new technology can improve data acquisition speed and image quality during MRI-guided biopsy and ablation procedures. The study operates under non-significant risk guidelines established by the FDA and involves thorough testing to ensure safety and system stability before in vivo use.
Who should consider this trial
Good fit: Ideal candidates include healthy volunteers or patients aged 18 and older who are already scheduled for an MRI-guided procedure.
Not a fit: Patients who are under 18 years of age or pregnant women will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved imaging techniques that enhance the accuracy and effectiveness of MRI-guided procedures.
How similar studies have performed: Other studies have shown promise in improving MRI-guided procedures, but this specific approach is novel in its focus on advanced imaging methods.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female. * Age ≥ 18 years. * Healthy volunteers or patients already scheduled for a MR-guided procedure. Exclusion Criteria: * Individuals 18 years of age. * Pregnant women.
Where this trial is running
Rochester, Minnesota
- Mayo Clinic in Rochester — Rochester, Minnesota, United States (RECRUITING)
Study contacts
- Principal investigator: Aiming Lu, PhD — Mayo Clinic
- Study coordinator: Desirae Howe-Clayton
- Email: howe.desirae@mayo.edu
- Phone: 507-255-0111
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Healthy, MRI-guided biopsy and/or ablation procedure